Vial Adaptors for Reconstitution Drug Market – (Ù…Øولات القوارير لإعادة تكوين سوق الأدوية) is projected to grow at a CAGR of 4.1% from 2024 to 2034 and cross US$ 816.6 Mn by the end of 2034.
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...
West Pharma introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack: Exton, Pennsylvania Thursday, January 23, 2025, 16:00 Hrs [IST] West Pharmaceutical Services ...
Hydrochloride for Injection, USP in two vial sizes: 25 mg/1 mL and 50 mg/2 mL, further broadening PCC's increasing portfolio ...
New Delhi: Drug major Glenmark Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under ...
UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile ...
Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...
The launch of Chlorpromazine Hydrochloride for Injection, USP (25mg/1mL and 50mg/2 mL vials) is the latest in a series of ...
U.K.-based CDMO Upperton Pharma Solutions expanded its production footprint with the completion of a new £7 million ($8.1 ...
Six start-ups bestowed with new ‘heart of pharma’ commendation in recognition of innovations advancing drug delivery and packagingWednesday 22nd January – Live from Porte De Versailles, ...
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback